Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.51M Buy
134,900
+33,507
+33% +$668K 0.01% 913
2026
Q1
$1.95M Buy
101,393
+43,652
+76% +$820K 0.01% 919
2025
Q4
$901K Buy
57,741
+9,852
+21% +$146K ﹤0.01% 1281
2025
Q3
$630K Sell
47,889
-280
-0.6% -$3.62K ﹤0.01% 1317
2025
Q2
$599K Buy
48,169
+4,821
+11% +$60.7K ﹤0.01% 1261
2025
Q1
$650K Buy
43,348
+16,747
+63% +$251K 0.01% 1015
2024
Q4
$393K Sell
26,601
-479
-2% -$7.48K ﹤0.01% 1186
2024
Q3
$432K Buy
+27,080
New +$481K 0.01% 932

Other funds holding NOV

&Partners's NOV Position: Q2 2026 in Review

&Partners increased its NOV (NOV) stake by 33% in Q2 2026, buying an estimated $668K and bringing the position to 134,900 shares worth $2.51M. The position accounts for 0.01% of the portfolio, ranked #913.

&Partners first reported a position in NOV in Q3 2024 and has held it in 8 quarters since. 488 funds tracked by Wall St. Rank hold NOV as of Q2 2026.

  • &Partners held 134,900 shares of NOV worth $2.51M as of Q2 2026.
  • &Partners bought 33,507 NOV shares in Q2 2026, an estimated $668K.
  • NOV made up 0.01% of &Partners's portfolio in Q2 2026, its #913 holding.
  • &Partners first reported a position in NOV in Q3 2024 and has held it in 8 quarters since.
  • 488 funds tracked by Wall St. Rank held NOV as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.